| ClinicalTrials.gov Identifier: |
NCT01927419 |
| Brief Title: |
Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma (CheckMate 069) |
|
|
First Submitted : |
August 20, 2013 |
|
First Submitted that Met QC Criteria : |
August 20, 2013 |
|
First Posted : |
August 22, 2013
(Estimate)
|
|
|
Results First Submitted : |
November 3, 2015 |
|
Results First Submitted that Met QC Criteria : |
January 8, 2016 |
|
Results First Posted : |
February 8, 2016
(Estimate)
|
|
|
Certification/Extension First Submitted : |
July 3, 2015 |
|
Certification/Extension First Submitted that Met QC Criteria :
|
July 17, 2015 |
|
Certification/Extension First Posted : |
August 7, 2015
(Estimate)
|
|
|
Last Update Submitted that Met QC Criteria : |
February 16, 2022 |
|
Last Update Posted : |
March 18, 2022
|
|
